Tarang Amin - 01 Oct 2025 Form 4/A - Amendment Insider Report for e.l.f. Beauty, Inc. (ELF)

Signature
/s/ Scott K. Milsten, Attorney-in-Fact for Tarang Amin
Issuer symbol
ELF
Transactions as of
01 Oct 2025
Net transactions value
-$12,074,743
Form type
4/A - Amendment
Filing time
10 Nov 2025, 16:16:51 UTC
Date Of Original Report
03 Oct 2025
Previous filing
02 Jul 2025
Next filing
13 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
AMIN TARANG Chief Executive Officer, Director C/O E.L.F. BEAUTY, INC., 570 10TH STREET, OAKLAND /s/ Scott K. Milsten, Attorney-in-Fact for Tarang Amin 10 Nov 2025 0001513988

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELF Common Stock, $0.01 par value Options Exercise $3,307,129 +194,537 +238% $17.00 276,355 01 Oct 2025 Direct F1, F2
transaction ELF Common Stock, $0.01 par value Sale $888,684 -6,817 -2.5% $130.36 269,538 01 Oct 2025 Direct F1, F2, F3
transaction ELF Common Stock, $0.01 par value Sale $4,356,335 -33,038 -12% $131.86 236,500 01 Oct 2025 Direct F1, F2, F4
transaction ELF Common Stock, $0.01 par value Sale $8,478,206 -64,030 -27% $132.41 172,470 01 Oct 2025 Direct F1, F2, F5
transaction ELF Common Stock, $0.01 par value Sale $1,658,648 -12,430 -7.2% $133.44 160,040 01 Oct 2025 Direct F1, F2, F6
holding ELF Common Stock, $0.01 par value 228,037 01 Oct 2025 By Family Trust
holding ELF Common Stock, $0.01 par value 228,037 01 Oct 2025 By Family Trust
holding ELF Common Stock, $0.01 par value 468,532 01 Oct 2025 By Amin Family General Partnership
holding ELF Common Stock, $0.01 par value 40,295 01 Oct 2025 By 2025 Family Trust I
holding ELF Common Stock, $0.01 par value 40,295 01 Oct 2025 By 2025 Family Trust II

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELF Stock Option (Right to Buy) Options Exercise $0 -194,537 -100% $0.000000 0 01 Oct 2025 Common Stock 194,537 $17.00 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025 and in connection with an exercise of stock options set to expire in September 2026. The sales reported herein were made solely to cover tax liabilities in connection with the exercise of stock options. The Reporting Person otherwise retained the remaining shares from the exercise.
F2 Includes 81,818 restricted stock units.
F3 The transaction was executed in multiple trades in prices ranging from $130.05 to $130.76, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The transaction was executed in multiple trades in prices ranging from $131.07 to $132.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5 The transaction was executed in multiple trades in prices ranging from $132.07 to $133.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6 The transaction was executed in multiple trades in prices ranging from $133.07 to $134.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F7 The stock option is fully vested and exercisable.

Remarks:

On October 3, 2025, the reporting person filed a Form 4 which inadvertently reported the wrong number of exercised shares.